| Purity: | 98 |
|---|---|
| Model Number: | C25H37NO4 |
| Brand Name: | NJ STERIOD |
| Usage: | Animal Pharmaceuticals |
| Grade Standard: | Medicine Grade |
| Type: | Auxiliaries and Other Medicinal Chemicals |
| Place of Origin: | China (Mainland) |
| EINECS No.: | C19H26O2 |
| CAS No.: | 155206-00-1 |
| 155206-00-1: | 1USD(changeable) |
Quick Details
Specifications
Product Name: Bimatoprost
Synonyms: N-ETHYL-9ALPHA, 11ALPHA, 15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z, 13E-DIEN-1-AMIDE; LUMIGAN; BIMATOPROST; BIMATOPROST(TM); 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE; BIMATOPROST(LUMIGAN); 17-phenyl-tri-norprostaglandin f2α-ethyl amide; (Z)-7-[(1R, 2R, 3R, 5S)-3,5-Dihydroxy-2-[(E, 3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
CAS: 155206-00-1
MF: C25H37NO4
MW: 415.57
Product Categories: Prostaglandins; Prostaglandin; Chiral Reagents; Intermediates & Fine Chemicals; Pharmaceuticals; Arachidonic Acid Cascade; Lipids in Cell Signaling; Lumigan; Cosmetics chemicals; Prostaglandins
mp 66-68°C
storage temp. -20°C
form solid
Chemical Properties Crystalline Solid
Usage Antiglaucoma. Synthetic prostamide; structurally related to prostaglandin F2a.
Usage Antiglaucoma. Synthetic prostamide; structurally related to prostaglandin F2α.
Usage Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. It ha
Usage Bimatoprost is an antiglaucoma agent. Bimatoprost is an synthetic prostamide; structurally related to prostaglandin F2α.
Product Description:
Bimatoprost (trade name Lumigan) is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.
In patients using ophthalmic prostaglandins such as travoprost and latanoprost, it has been anecdotally noted that there had been an increase in diameter, density and length of eyelashes. Allergan initiated clinical trials investigating the usage of Lumigan as a cosmetic drug.